Document Detail


Survival and phase sensitivity of HeLa cells treated with dianhydrogalactitol (NSC-132313).
MedLine Citation:
PMID:  1203879     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of dianhydrogalactitol on survival and phase sensitivity of the cell cycle of HeLa cells was studied. In survival experiments no cells survived when the drug was added and left in contact with the cells at or above a dose of 0.7 mug/ml. Cells synchronized by the mitotic-selection method showed changing sensitivity to the drug during the cell cycle. G, late-S, and M phases were more sensitive to dianhydrogalactitol than the early-S and G phases. The DNA synthetic phase was divided into an early low sensitive and a late highly sensitive stage. The different sensitivity of mid-G and early-S phases was further established in separate survival experiments. Cells treated in G phase entered M phase in a manner similar to untreated control cells, while the progress of cells in S or G phase during treatment was delayed significantly. Lack of phase specificity of this drug is consistent with that of other alkylating agents. Changing sensitivity during some phases of the cell cycle proves that some metabolic events are especially sensitive to this particular drug.
Authors:
I Pályi
Related Documents :
18458079 - Cdc6 determines utilization of p21(waf1/cip1)-dependent damage checkpoint in s phase ce...
22324849 - An interplay between centrin2 and centrin4 on the bi-lobed structure in trypanosoma bru...
21648019 - Challenging the pluripotency of human testis-derived esc-like cells.
6203849 - Cell cycle-related changes in number of t-lymphocyte receptors for glucocorticoids and ...
6501429 - Cell cycle regulation by environmental ph.
6606589 - Cytoplasmic phases in the first cell cycle of the activated frog egg.
21277309 - Cell renewal in adjoining intestinal and tracheal epithelia of manduca.
8386649 - Pathogenesis of testicular germ cell tumours.
23376999 - Mice lacking the sodium-dependent phosphate import protein, pit1 (slc20a1), have a seve...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer chemotherapy reports. Part 1     Volume:  59     ISSN:  0069-0112     ISO Abbreviation:  Cancer Chemother Rep     Publication Date:    1975 May-Jun
Date Detail:
Created Date:  1976-03-30     Completed Date:  1976-03-30     Revised Date:  2008-02-20    
Medline Journal Info:
Nlm Unique ID:  7607105     Medline TA:  Cancer Chemother Rep     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  493-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Division / drug effects
Cell Survival / drug effects
DNA Replication / drug effects
Dose-Response Relationship, Drug
Ethers, Cyclic / pharmacology
Hela Cells / drug effects*
Mitosis / drug effects
Sugar Alcohols / pharmacology*
Time Factors
Chemical
Reg. No./Substance:
0/Ethers, Cyclic; 0/Sugar Alcohols

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A metastasising ameloblastoma associated with renal calculi and hypercalcaemia.
Next Document:  Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.